Resource Centre
Publication )
Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy
Webinar )
Advancing rAAV Characterisation with Oxford Nanopore Sequencing
Brochure )
Brochure: biopharma — cell and gene therapies
Getting started guide )
Getting started guide: biopharma
Workflow )
Workflow overview: amplicon sequencing
Publication )
Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario
Workflow )
Workflow overview: pharmacogenomics with adaptive sampling
Case study Case study: streamlining routine CRISPR validation with Oxford Nanopore sequencing
Workflow )
Workflow overview: AAV sequencing
Video )
Webinar: Rapid, comprehensive AAV genomic profiling made simple
Publication )
Long read sequencing reveals transgene concatemerisation and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes
Poster )
EPI2ME end-to-end workflows for biopharma quality control of plasmids and mRNA
Video )
Stepping into the future of nanopore protein sequencing
Video )
Nanopore sequencing reveals psilocybin-induced brain 5mC/5hmC epigenetic changes
Video )
Masterclass: How to sequence full-length plasmids in your own lab | LC25
Brochure )
Flyer: pharmacogenomics with Twist
Publication )
A sensitive sample preparation pipeline for adventitious virus detection using Oxford Nanopore sequencing
Publication Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing
Brochure )
Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore
Publication )
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines
